Navigation Links
The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
Date:10/25/2007

8 million and $3.9 million, respectively, for the third quarter and nine-months ended September 30, 2007 as a reduction in the number of active independent distributor representatives reflects the effects of ongoing litigation, which the Company is vigorously pursuing with the sponsor of the Company's product line in this segment. Corrective actions continue to be taken to resolve the litigation and increase the number of active independent distributor representatives as part of strategic efforts with the goal to increase sales and return to profitability.

No tax provision or benefits, to reduce losses, are provided for the quarter and nine-months ended September 30, 2007 and 2006, except for any requirements imposed by the federal alternative minimum taxes or for compliance with state tax regulations, since the Company is in a net operating loss carry-forward position.

The research by the Company is part of its strategic initiatives to generate future growth. These initiatives include capitalizing on the growth potential of Quigley Pharma, a wholly-owned Ethical Pharmaceutical subsidiary, by developing natural-source potential prescription products for Systemic Radiation, Rheumatoid Arthritis, Avian Flu in animals and particularly, Diabetic Peripheral Neuropathy.

During the third quarter of 2007, a human safety study was undertaken to investigate the effects of QR-449, a broad spectrum anti-inflammatory compound, on patients suffering from Metabolic Syndrome, a condition which inhibits normal metabolic processes. Metabolic Syndrome sufferers are vulnerable to dangerous heart attack risk factors including diabetes, abdominal obesity, high cholesterol and high blood pressure. Inflammation plays a major role in this condition as well as Rheumatoid Arthritis, Cancer and Cachexia.

The primary objectives for the study are the determination of safety and to measure the corrective capacity of the compound on the imbalance of important anti-oxidant,
'/>"/>

SOURCE The Quigley Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
2. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
4. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
5. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
6. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 The Lupus Foundation of ... LLY ) today released results from UNVEIL: understanding the ... on the lupus journey and the challenges not only ... caregivers. The UNVEIL study, which involved over 1,000 people ... lupus has on all aspects of life including family, ...
(Date:9/16/2014)... Sept. 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... to delivering high quality and novel medicines to physicians ... Executive Officer Mark Baum will be a ... Select Conference in New York City.  Mr. Baum will ... Dropless™ campaign in ophthalmology. The presentation is scheduled for ...
(Date:9/16/2014)... -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing ... today that it has entered into an agreement with ... of animal studies for levorphanol, the active ingredient of ... levorphanol.  Gavril Pasternak, MD, PhD, of MSKCC is the ... Pasternak said, "Levorphanol is a unique opioid analgesic that ...
Breaking Medicine Technology:"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... WORTH, Texas, March 22, 2012  The Board of Directors of ... innovator in advanced wound care solutions, announced today that Robert ... of the Company.  In addition, Scott A. Haire has resigned ... Executive Officer of the Company, and Deborah Jenkins Hutchinson has ...
... 22, 2012  Argon Medical Devices, Inc. announced today ... catheter, licensed from Rex Medical, LP, designed to ... treatments. "UltraStream provides clinicians with an ... life for their patients," commented George Leondis, President ...
Cached Medicine Technology:Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 2Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 3Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter 2
(Date:9/16/2014)... As part of Child Passenger Safety Week, which ... Amica Insurance is reminding parents and caregivers ... in the car. , According to a 2012 ... (NHTSA), 20 percent of drivers of child passengers admitted ... child restraints. However, 90 percent of those same drivers ...
(Date:9/16/2014)... PA (PRWEB) September 16, 2014 Former ... well today after undergoing successful heart transplantation surgery at ... Mr. Tekulve, who spent most of his 16-year baseball ... team as a commentator for Root Sports Pittsburgh, was ... transplant surgeon, Stephen Bailey, MD, surgical director of AGH’s ...
(Date:9/16/2014)... everyday, but that doesn,t mean the findings are put ... the neonatal mortality rate is 10 times higher than ... applying an inexpensive topical solution of chlorhexidine to cleanse ... by 24 percent, many Indian parents did not receive ... that we don,t have solutions to solve major societal ...
(Date:9/16/2014)... 2014 A team of researchers at Boston University ... new model to study the motion patterns of bacteria ... relate to communication within a bacterial colony. , The ... bacteria to a microcantilever a microscopic beam anchored ... thus coupling its motion to that of the bacteria. ...
(Date:9/16/2014)... 15, 2014A prospective study that compared patient-reported outcomes ... bone metastases demonstrates that single fraction radiation therapy ... radiation therapy (MFRT) when pain, function and quality ... today at the American Society for Radiation Oncology,s ... that improvements in patients, pain, function and degree ...
Breaking Medicine News(10 mins):Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Pairing social networks with social motives to close the science gap 2Health News:Pairing social networks with social motives to close the science gap 3Health News:And so they beat on, flagella against the cantilever 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4
... rest of nation, , , TUESDAY, Feb. 10 (HealthDay News) -- A ... pain has more than doubled in that state since the early ... in the country as a whole. , "We were actually ... professor of medicine at the University of North Carolina and the ...
... of Americans age 65 and older have prescription drug coverage ... according to a University of Michigan analysis. And poor seniors ... , The analysis compares drug coverage among a nationally ... both in 2004 and after the Medicare Part D prescription ...
... National Leaders in the Effort to Improve Long-Term Care ... SCAN Foundation announced today that two of America,s leading ... for the elderly, Jennie Chin Hansen, R.N., ... named to The SCAN Foundation board of directors.Bruce Chernof, ...
... in Barry Willer,s office at the University at Buffalo was ... a relatively mild traumatic brain injury, and he was doing ... best efforts, the man,s wife described him to friends as ... Willer, UB professor of psychiatry and a specialist in traumatic ...
... Government contract; $28.5 million in contract year one- ... drives revenue for first half- Earnings per share ... Strong balance sheet with $2.1 million in cash, ... Feb. 10 Sharps Compliance Corp. (OTC Bulletin ...
... The Animal Research Minute is a daily report of ... Feb. 10 The Foundation for Biomedical Research (FBR) ... radio broadcast, The Animal Research Minute, nationally after experiencing ... Minute is an educational report of the day,s medical ...
Cached Medicine News:Health News:Chronic Low Back Pain Is on the Rise 2Health News:Chronic Low Back Pain Is on the Rise 3Health News:Most seniors have drug coverage, study shows 2Health News:The SCAN Foundation Names New Members to Its Board 2Health News:The SCAN Foundation Names New Members to Its Board 3Health News:Brain-injured patients can relearn emotions 2Health News:Brain-injured patients can relearn emotions 3Health News:Brain-injured patients can relearn emotions 4Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 2Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 3Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 4Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 5Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 6Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 7Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 8Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 9Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 10Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 11Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 12Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 13Health News:Foundation for Biomedical Research Announces National Distribution of Daily Radio Broadcast 2
... ACS allows visualization of virtually the ... essentially coaxial positioning of the lens on ... detachment surgery, repairing giant retinal tears, diagnosing ... examining the peripheral retina in a vitreous ...
... somewhat higher magnification and increased ... best suited for detailed visualization ... Central Retinal is ideal for ... membrane peeling in proliferative vitreoretinopathy ...
... MiniQuad allows visualization of virtually the ... with essentially coaxial positioning of the ... excellent for retinal detachment surgery, repairing ... anterior proliferative vitreoretinopathy and for examining ...
... Lens enhances iridectomy procedures by providing ... conventional iridectomy lens designs) with exceptional ... this lens has been increased from ... The MagPlus comes standard with LaserWindow ...
Medicine Products: